Yixintang Pharmaceutical Group Co., Ltd.

SZSE:002727.SZ

21.31 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2024202320222021202020192018201720162015201420132012201120102009
Omzet 18,000.45517,301.37917,431.61614,587.40112,656.28410,479.0939,176.277,751.1396,249.3365,321.1524,428.413,546.6622,842.142,218.5081,850.1661,455.978
Kosten van de omzet 12,278.18611,750.34611,322.2989,196.528,122.9616,424.1325,457.0274,532.5263,669.3983,090.2992,637.7632,142.4571,757.9651,355.9131,159.918924.977
Brutowinst 5,722.2695,551.0336,109.3185,390.8824,533.3234,054.9613,719.2433,218.6142,579.9382,230.8531,790.6471,404.2051,084.174862.595690.248531.001
Brutowinstmarge 0.3180.3210.350.370.3580.3870.4050.4150.4130.4190.4040.3960.3810.3890.3730.365
Onderzoek- en ontwikkelingskosten 9.71310.2048.7445.390.8390.2390.146000000000
Algemene en administratieve kosten 85.54479.33167.06764.6168.66372.44555.40949.64756.10760.21647.7429.74142.9335.032104.23577.441
Verkoop- en marketingkosten 679.9762,935.8624,071.8613,700.7053,051.8012,834.2682,454.5742,157.1681,750.5391,475.6131,123.711919.223693.711551.897444.653327.981
Verkoop-, algemene en administratieve kosten 765.5214,684.4384,138.9283,765.3153,120.4642,906.7122,509.9832,206.8151,806.6461,535.8291,171.451948.964736.641586.929548.888405.421
Overige kosten 4,668.99690.11349.127320.56437.646343.329414.345367.83118.45212.8362.3756.4196.3352.0292.384-4.539
Bedrijfskosten 5,444.234,784.7534,496.84,091.2663,558.9493,250.282,924.4742,574.6462,110.1131,791.6321,386.7351,117.645867.411694.52559.779414.467
Bedrijfsresultaat 278.039786.4441,661.8811,067.942917.928739.219684.329687.382392.578379.015344.427264.343198.888156.325123.946109.78
Bedrijfsresultaat ratio 0.0150.0450.0950.0730.0730.0710.0750.0890.0630.0710.0780.0750.070.070.0670.075
Totaal overige inkomsten en kosten netto -70.728-83.88-7.7428.5838.9649.8317.346-140.52418.30911.1130.9175.606-11.9421.5781.913-5.015
Inkomen voor belasting 207.311702.5641,234.9781,096.523956.893749.05691.675546.858409.381390.127345.343269.949204.821157.903125.858104.765
Inkomen voor belasting ratio 0.0120.0410.0710.0750.0760.0710.0750.0710.0660.0730.0780.0760.0720.0710.0680.072
Belastingkosten 97.018142.151222179.316167.727145.732171.9124.11255.81443.68950.29830.58922.85225.14124.41120.003
Nettowinst 114.138549.4421,009.996921.584789.96603.918521.07422.714353.377346.439297.309240.853182.551134.71102.94584.849
Nettowinstmarge 0.0060.0320.0580.0630.0620.0580.0570.0550.0570.0650.0670.0680.0640.0610.0560.058
WPA (Winst Per Aandeel) 0.190.921.71.561.381.060.920.810.680.670.650.620.470.350.280.24
Verwaterde WPA 0.190.921.71.561.381.060.920.810.680.670.650.620.470.350.280.24
EBITDA 1,611.5242,182.1042,539.7352,448.4131,074.829856.189813.63677.35513.406461.906390.8298.566239.179187.111132.686118.248
EBITDA ratio 0.090.1260.1460.1680.0850.0820.0890.0870.0820.0870.0880.0840.0840.0840.0720.081